GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VitaSpring Biomedical Co Ltd (OTCPK:VSBC) » Definitions » Equity-to-Asset

VSBC (VitaSpring Biomedical Co) Equity-to-Asset : 0.69 (As of Oct. 2022)


View and export this data going back to 2019. Start your Free Trial

What is VitaSpring Biomedical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. VitaSpring Biomedical Co's Total Stockholders Equity for the quarter that ended in Oct. 2022 was $1.68 Mil. VitaSpring Biomedical Co's Total Assets for the quarter that ended in Oct. 2022 was $2.44 Mil.

The historical rank and industry rank for VitaSpring Biomedical Co's Equity-to-Asset or its related term are showing as below:

VSBC's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.68
* Ranked among companies with meaningful Equity-to-Asset only.

VitaSpring Biomedical Co Equity-to-Asset Historical Data

The historical data trend for VitaSpring Biomedical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VitaSpring Biomedical Co Equity-to-Asset Chart

VitaSpring Biomedical Co Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22
Equity-to-Asset
Get a 7-Day Free Trial -0.23 -0.64 - 0.51 0.44

VitaSpring Biomedical Co Quarterly Data
Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.44 0.70 0.69 0.69

Competitive Comparison of VitaSpring Biomedical Co's Equity-to-Asset

For the Biotechnology subindustry, VitaSpring Biomedical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VitaSpring Biomedical Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VitaSpring Biomedical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where VitaSpring Biomedical Co's Equity-to-Asset falls into.


;
;

VitaSpring Biomedical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

VitaSpring Biomedical Co's Equity to Asset Ratio for the fiscal year that ended in Jan. 2022 is calculated as

Equity to Asset (A: Jan. 2022 )=Total Stockholders Equity/Total Assets
=1.578/3.604
=0.44

VitaSpring Biomedical Co's Equity to Asset Ratio for the quarter that ended in Oct. 2022 is calculated as

Equity to Asset (Q: Oct. 2022 )=Total Stockholders Equity/Total Assets
=1.681/2.443
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VitaSpring Biomedical Co  (OTCPK:VSBC) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


VitaSpring Biomedical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


VitaSpring Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
400 Spectrum Center Dr. No. 1620, Irvine, CA, USA, 92618
VitaSpring Biomedical Co Ltd is a start-up business company. The company's objective is to develop new drugs in cell medicine. The company also plans to produce X.MSC cytopharmaceuticals.

VitaSpring Biomedical Co Headlines

No Headlines